Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 21, 2014; 20(47): 17877-17882
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.17877
Figure 6
Figure 6 Interferon treatment and serum thymus and activation-regulated chemokine levels in chronic hepatitis C. The mean serum TARC levels of the non-IFN and IFN groups were 166.8 ± 79.1 pg/ml and 173.3 ± 92.1 pg/mL, respectively; the difference in TARC levels between the two groups was not significant (P = 0.8199). TARC: Thymus and activation-regulated chemokine; IFN: Interferon.